Sharechat Logo

MARKET CLOSE: NZ shares drop on Z downgrade, Ryman and NZX fall

Wednesday 18th July 2018

Text too small?

New Zealand shares fell, led by Z Energy following an earnings downgrade, with Ryman Healthcare and NZX also declining.

The S&P/NZX50 Index dropped 32.79 points, or 0.4 percent, to 8,964.1. Within the index, 29 stocks fell, 11 rose and 10 were unchanged. Turnover was $123.3 million.

"The index has had a bit of a soft week, and there's not any one stock that's doing enough to explain today's weakness," said Grant Davies, investment advisor at Hamilton Hindin Greene. The local benchmark index underperformed its regional peers, with Australia's ASX 200 up 0.7 percent at 5pm New Zealand time, while China's CSI 300 rose 0.5 percent and Japan's Nikkei 400 up 0.5 percent. 

The weakest stock on the index was Z Energy, down 2.7 percent to $7.30. The country’s biggest fuel retailer cut full-year earnings guidance by $30 million due to an extended shutdown at the Marsden Point oil refinery and high crude prices in the June quarter.

The company is now forecasting operating earnings of $420 million to $455 million for the year through March 2019, down from previous guidance of $450 million to $485 million in earnings before interest, tax, depreciation and changes in financial instruments.

In the latest financial year, which ended March 31 2018, Z's net profit rose 16 percent to $205 million on the same basis as the firm benefited from strong jet fuel and diesel demand and ongoing synergy gains from its acquisition.

"Z's margins have been in the news for a while now, and it's maybe an opportune time if they want to head off regulatory action," Davies said. "The market is not throwing its toys too much. The stock is slightly down this year, it has been pretty stagnant on political threats to margins and this has made them a bit more cautious." 

The stock is down 2.2 percent this year as the government looks more closely at pricing strategy in the fuel sector, with the Commerce Commission set to gain market studies powers by the end of 2018 and the industry top of the list for such an investigation.

Ryman Healthcare dropped 2 percent to $12.05, NZX fell 1.8 percent to $1.10, and Gentrack Group declined 1.3 percent to $6.88.

Chorus was the best performer, rising 1.7 percent to $4.32. Port of Tauranga gained 1.4 percent to $5.07 and Kathmandu Holdings advanced 1.3 percent to $3.11.

Outside the benchmark index, Pyne Gould Corp was unchanged at 30 cents. Its Torchlight Fund has 30 months to make a fixed redemption payment of A$25.5 million after the firm announced a deal with unhappy investors who pursued the distressed asset investor through the Cayman Islands courts.


  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

NZ dollar falls with Aussie after Westpac's RBA rate cut call
Intuit juggernaut grows QuickBooks subscribers but momentum slows
Reaction to Budget rules relaxation shows balance 'about right', says Ardern
Augusta lifts net profit six fold as investors flock into new funds
Annual exports to China top $15 billion for first time
Gentrack posts $8.7M loss on CA Plus write-down
Westpac says RBNZ capital proposals would add $6,000 p.a. to an Auckland mortgage
Cavalier says market conditions still challenging
Ryman hikes dividend as annual earnings grow on wider development margin
24th May 2019 Morning Report

IRG See IRG research reports